Compliance related to payments to physicians is important to all health systems, given the risks. HSG has extensive experience evaluating Fair Market Value Opinions (FMV) and commercial reasonableness related to compensation, medical directorships, acquisitions, and other transactions with physicians.
For more information on fair market value and commercial reasonableness opinions, call Neal Barker at (502) 814-1189.
RELATED THOUGHT LEADERSHIP

May 13, 2021
Physician Compensation Risk Assessment: New Final Rule Creates Challenges in Determining Fair Market Value and Commercial Reasonableness
Physician Compensation: 2021 MPFS Final Rule Creates Unique Fair Market Value and Commercial Reasonableness Risk Assessment Challenges

April 10, 2021
The 2021 Stark Law and Anti-Kickback Statute: Fair Market Value and Commercial Reasonableness (American Health Law Association Publication)
Noteworthy 2021 stark law revisions and modifications: specifically areas impacting provider compensation and transactions valuation.

April 20, 2020
AHLA – Anesthesia Subsidy Assessment: Fair Market Value and Beyond
This article will discuss the central focus of a typical anesthesia subsidy assessment and appraisal—fair market value for provider salaries and benefits.
TESTIMONIALS
“HSG completed an assessment of our anesthesia staffing, our group’s revenue cycle function and operations, as well as other factors affecting our anesthesia subsidy. HSG listened to our specific needs, they talked to our anesthesiologists, CRNAs, and OR leadership, and came to understand our culture, our specific challenges, and our unique needs. They validated what we were doing in some areas and made impactful recommendations for our health system and our relationship with anesthesia going forward. HSG did an exceptional job for us.”
Jeremy Biggs – President and Chief Administration Officer of Methodist Medical Center of Oak Ridge

Or fill this out and I'll be in touch: